Accuray Inc Moves Listing to Nasdaq Capital Market; $1.00 Bid-Price Cure Period

What Happened
Accuray Incorporated (ARAY) announced that Nasdaq approved the transfer of its common stock from the Nasdaq Global Select Market to the Nasdaq Capital Market. Nasdaq granted the approval on August 4, 2026, and the Company’s common stock began trading on the Nasdaq Capital Market at the opening of business on August 6, 2026. The stock will continue to trade under the ticker "ARAY."

Key Details

• Nasdaq approval received: August 4, 2026; listing transfer effective: opening of business August 6, 2026.
• Ticker unchanged: ARAY.
• Accuray was granted an additional 180 days (until February 1, 2027) to regain compliance with the Nasdaq Capital Market $1.00 minimum bid price requirement.
• Nasdaq Capital Market requires listed companies to meet certain financial and corporate governance standards similar in many respects to the Global Select Market.

Why It Matters
For investors, the listing tier change is a regulatory and visibility event: the stock remains listed and tradable, but the Company is on the Nasdaq Capital Market and must demonstrate a $1.00 minimum bid price by February 1, 2027 to maintain compliance. If Accuray does not meet the bid-price requirement within the cure period, Nasdaq could initiate delisting procedures under its rules. The 8‑K reports only the listing transfer and the extension for bid-price compliance; it does not report other corporate or financial changes.